Compare Organon Pharma Indonesia Tbk. (SCPI) vs Sumber Tani Agung Resources Tbk (STAA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Sumber Tani Agung Resources Tbk — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Sumber Tani Agung Resources Tbk trades at Rp1,190 (market cap 13.74T, 4.09M 24h volume). The key difference: Sumber Tani Agung Resources Tbk is far larger — about 131.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | STAA | |
|---|---|---|
Market Cap | 104.4B | 13.74T |
Volume | — | 4.09M |
Lot | — | 40.89K |
Turnover | — | 5.01B |
Average Price | — | 1,226.35 |
Value | — | 5.01B |
Indicative Equilibrium Price | — | 1,190 |
Indicative Equilibrium Volume | — | 1.22K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Sumber Tani Agung Resources Tbk
PT Sumber Tani Agung Resources Tbk (the Company) (formerly PT Sinarlika Portibijaya Plantation) was established on July 31, 1993 based on the Notarial Deed No. 189 of Reny Helena Hutagalung, S.H., Notary in Medan. The Company has operated its palm oil processing factory since May 2010.
Read more on STAA →
